CompletedEarly Phase 1

Effects of Rocking on Postoperative Ileus Duration Study

United States66 participantsStarted 2005-07

Plain-language summary

Primary Objective: 1\. Compare the duration of postoperative ileus (POI) duration (time to first flatus), subjective reports of surgical and gas pain, postoperative pain medication (total milligrams per 24 hours) and postoperative recovery time(length of stay) between two groups of abdominal surgery cancer patients receiving either standard postoperative care or standard care plus the rocking intervention.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Post abdominal surgical cancer patient, undergoing abdominal surgery
✓. Over 21 years of age.
✓. Ambulatory.
✓. Cognitively intact.
✓. Scheduled to have epidural analgesia with fentanyl or dilaudid and/or patient controlled analgesia with morphine or dilaudid as their primary mode of postoperative pain control.

Exclusion criteria

✕. Postoperative abdominal surgical cancer patient less than 21 years of age.
✕. Are not ambulatory.
✕. Are not cognitively intact.
✕. Have any of the following: severe neuromuscular disease, cardiovascular disease, pacemakers, inner-ear disturbances, known peripheral vascular disease that interferes with ambulation, are on sympathetic inhibitory or mood altering drugs. All patients will have epidural and/or patient controlled analgesia as their primary mode of postoperative pain control and those who do not will be excluded.

What they're measuring

Time to First Postoperative Flatus in Days Was the End of Postoperative Ileus (POI) Indicator.

Timeframe: Daily from first day after surgical procedure to passage of first flatus (up to 5 - 7 days post surgery).

Trial details

NCT IDNCT00494806

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-02

Results submitted2009-08-31

View on ClinicalTrials.gov More Abdominal Cancer trials